Literature DB >> 14618262

Redefining tumour suppressor genes: exceptions to the two-hit hypothesis.

A J W Paige1.   

Abstract

Knudson's two-hit model of tumour suppressor genes supposes that two mutations are required to cause a tumour, one occurring in each of the two alleles of the gene. Many such cancer genes exhibiting biallelic disruption and truncating point mutations have been identified, revealing the success of the model. Despite changes in our concept of cancer genes, two inactivating point mutations are still considered the hallmark of tumour suppressor genes. Recently, however, more and more reports describe candidate tumour suppressors that do not conform to this standard definition, including haploinsufficient genes requiring inactivation of only one allele, and genes inactivated not by mutation but rather epigenetic hypermethylation. This review describes some of these exceptions and proposes a revised tumour suppressor gene definition to facilitate the identification of this new generation of tumour suppressor loci.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14618262     DOI: 10.1007/s00018-003-3027-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  17 in total

Review 1.  Cancer-selective apoptotic effects of extracellular and intracellular Par-4.

Authors:  T Shrestha-Bhattarai; V M Rangnekar
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

2.  PML: An emerging tumor suppressor and a target with therapeutic potential.

Authors:  Erin L Reineke; Hung-Ying Kao
Journal:  Cancer Ther       Date:  2009-09-01

3.  Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms.

Authors:  Agnes Fütterer; Miguel R Campanero; Esther Leonardo; Luis M Criado; Juana M Flores; Jesús M Hernández; Jesús F San Miguel; Carlos Martínez-A
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

Review 4.  Apoptosis and tumor resistance conferred by Par-4.

Authors:  Yanming Zhao; Vivek M Rangnekar
Journal:  Cancer Biol Ther       Date:  2008-12-08       Impact factor: 4.742

5.  Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing.

Authors:  Mitchell S Stark; Susan L Woods; Michael G Gartside; Vanessa F Bonazzi; Ken Dutton-Regester; Lauren G Aoude; Donald Chow; Chris Sereduk; Natalie M Niemi; Nanyun Tang; Jonathan J Ellis; Jeffrey Reid; Victoria Zismann; Sonika Tyagi; Donna Muzny; Irene Newsham; YuanQing Wu; Jane M Palmer; Thomas Pollak; David Youngkin; Bradford R Brooks; Catherine Lanagan; Christopher W Schmidt; Bostjan Kobe; Jeffrey P MacKeigan; Hongwei Yin; Kevin M Brown; Richard Gibbs; Jeffrey Trent; Nicholas K Hayward
Journal:  Nat Genet       Date:  2011-12-25       Impact factor: 38.330

Review 6.  Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine.

Authors:  Krysta Mila Coyle; Jeanette E Boudreau; Paola Marcato
Journal:  Biomed Res Int       Date:  2017-06-08       Impact factor: 3.411

7.  Important genes in the pathogenesis of 5q- syndrome and their connection with ribosomal stress and the innate immune system pathway.

Authors:  Ota Fuchs
Journal:  Leuk Res Treatment       Date:  2012-02-13

8.  Deficiency in PER proteins has no effect on the rate of spontaneous and radiation-induced carcinogenesis.

Authors:  Marina P Antoch; Ilia Toshkov; Karen K Kuropatwinski; Marilyn Jackson
Journal:  Cell Cycle       Date:  2013-10-02       Impact factor: 4.534

9.  Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype.

Authors:  Simone Feurstein; Frank G Rücker; Lars Bullinger; Winfried Hofmann; Georgi Manukjan; Gudrun Göhring; Ulrich Lehmann; Michael Heuser; Arnold Ganser; Konstanze Döhner; Brigitte Schlegelberger; Doris Steinemann
Journal:  BMC Genomics       Date:  2014-09-11       Impact factor: 3.969

10.  The importance of nerve microenvironment for schwannoma development.

Authors:  Alexander Schulz; Robert Büttner; Christian Hagel; Stephan L Baader; Lan Kluwe; Johannes Salamon; Victor-Felix Mautner; Thomas Mindos; David B Parkinson; Jeffrey R Gehlhausen; D Wade Clapp; Helen Morrison
Journal:  Acta Neuropathol       Date:  2016-05-28       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.